Invesco’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9M Sell
99,596
-909
-0.9% -$131K ﹤0.01% 1692
2025
Q4
$14.3M Sell
100,505
-10,645
-10% -$1.43M ﹤0.01% 1642
2025
Q3
$13.3M Sell
111,150
-101,568
-48% -$12.9M ﹤0.01% 1654
2025
Q2
$28.1M Buy
212,718
+8,891
+4% +$1.21M ﹤0.01% 1290
2025
Q1
$28.3M Buy
203,827
+90,674
+80% +$14.1M 0.01% 1277
2024
Q4
$17.6M Buy
113,153
+12,489
+12% +$2.11M ﹤0.01% 1557
2024
Q3
$18.3M Sell
100,664
-5,576
-5% -$826K ﹤0.01% 1506
2024
Q2
$12.6M Sell
106,240
-11,424
-10% -$1.2M ﹤0.01% 1675
2024
Q1
$12.6M Buy
117,664
+7,670
+7% +$763K ﹤0.01% 1693
2023
Q4
$11M Buy
109,994
+65,544
+147% +$6.41M ﹤0.01% 1759
2023
Q3
$5.29M Sell
44,450
-230
-0.5% -$34.3K ﹤0.01% 2177
2023
Q2
$7.96M Sell
44,680
-5,027
-10% -$922K ﹤0.01% 1970
2023
Q1
$8.2M Sell
49,707
-87,525
-64% -$15.1M ﹤0.01% 1949
2022
Q4
$21.6M Buy
137,232
+12,288
+10% +$1.87M 0.01% 1334
2022
Q3
$18.8M Sell
124,944
-4,284
-3% -$713K 0.01% 1354
2022
Q2
$21.2M Buy
129,228
+8,496
+7% +$1.64M 0.01% 1330
2022
Q1
$26.9M Buy
120,732
+6,013
+5% +$1.35M 0.01% 1312
2021
Q4
$27.2M Sell
114,719
-88,183
-43% -$20.6M 0.01% 1360
2021
Q3
$47.4M Sell
202,902
-128
-0.1% -$26.8K 0.01% 1074
2021
Q2
$41.8M Sell
203,030
-5,435
-3% -$1.12M 0.01% 1159
2021
Q1
$42.8M Sell
208,465
-3,292
-2% -$695K 0.01% 1127
2020
Q4
$45.4M Buy
211,757
+102,864
+94% +$20M 0.01% 1061
2020
Q3
$19.9M Buy
108,893
+3,732
+4% +$703K 0.01% 1307
2020
Q2
$19.4M Sell
105,161
-9,222
-8% -$1.83M 0.01% 1285
2020
Q1
$23.1M Buy
114,383
+17,763
+18% +$3.42M 0.01% 1132
2019
Q4
$18.1M Sell
96,620
-25,776
-21% -$4.44M 0.01% 1488
2019
Q3
$19.5M Sell
122,396
-305,837
-71% -$60.9M 0.01% 1425
2019
Q2
$108M Buy
428,233
+93,904
+28% +$21.8M 0.03% 650
2019
Q1
$80M Buy
334,329
+3,176
+1% +$762K 0.03% 611
2018
Q4
$76M Sell
331,153
-4,272
-1% -$1.05M 0.03% 577
2018
Q3
$94.8M Buy
335,425
+37,727
+13% +$11.1M 0.03% 577
2018
Q2
$87.4M Buy
297,698
+42,477
+17% +$11.6M 0.03% 594
2018
Q1
$64.4M Sell
255,221
-90,199
-26% -$21.2M 0.02% 638
2017
Q4
$74.6M Buy
345,420
+18,983
+6% +$3.84M 0.03% 599
2017
Q3
$60.7M Buy
326,437
+3,755
+1% +$655K 0.02% 683
2017
Q2
$55.7M Sell
322,682
-12,168
-4% -$1.95M 0.02% 725
2017
Q1
$51.1M Buy
334,850
+2,963
+0.9% +$433K 0.02% 775
2016
Q4
$48.9M Buy
331,887
+10,143
+3% +$1.47M 0.02% 787
2016
Q3
$40.7M Buy
321,744
+273,026
+560% +$32.9M 0.01% 859
2016
Q2
$5.49M Sell
48,718
-11,859
-20% -$1.23M ﹤0.01% 1857
2016
Q1
$6.31M Sell
60,577
-8,605
-12% -$823K ﹤0.01% 1690
2015
Q4
$7.8M Buy
69,182
+3,278
+5% +$362K ﹤0.01% 1595
2015
Q3
$7.22M Buy
65,904
+23,179
+54% +$2.48M ﹤0.01% 1624
2015
Q2
$4.09M Buy
42,725
+4,968
+13% +$464K ﹤0.01% 2155
2015
Q1
$3.52M Sell
37,757
-3,551
-9% -$311K ﹤0.01% 2230
2014
Q4
$3.38M Buy
41,308
+3,544
+9% +$272K ﹤0.01% 2184
2014
Q3
$2.42M Sell
37,764
-589
-2% -$36.1K ﹤0.01% 2423
2014
Q2
$2.33M Sell
38,353
-8,064
-17% -$476K ﹤0.01% 2483
2014
Q1
$2.78M Buy
46,417
+3,729
+9% +$230K ﹤0.01% 2342
2013
Q4
$2.72M Sell
42,688
-3,261
-7% -$210K ﹤0.01% 2458
2013
Q3
$3.12M Buy
45,949
+3,403
+8% +$243K ﹤0.01% 2238
2013
Q2
$3.07M Buy
+42,546
New +$2.81M ﹤0.01% 2123

Other funds holding ICUI

Invesco's ICUI Position: Q1 2026 in Review

Invesco reduced its ICU Medical (ICUI) stake by 0.9% in Q1 2026, selling an estimated $131K and leaving 99,596 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1692.

Invesco first reported a position in ICUI in Q2 2013 and has held it in 52 quarters since. The position peaked at $108M in Q2 2019. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Invesco held 99,596 shares of ICU Medical worth $12.9M as of Q1 2026.
  • Invesco sold 909 ICU Medical shares in Q1 2026, an estimated $131K.
  • ICU Medical made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #1692 holding.
  • Invesco first reported a position in ICU Medical in Q2 2013 and has held it in 52 quarters since.
  • Invesco's ICU Medical position peaked at $108M in Q2 2019.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.